ARTICLE | Company News
Lynx, AstraZeneca in asthma deal
March 20, 2001 8:00 AM UTC
LYNX will apply its Megatype technology to DNA samples from AstraZeneca (AZN; LSE:AZN) to discover SNPs associated with asthma. LYNX will receive payments from AZN at the beginning of the project and ...